The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV has made revisions to address U.S. Food and Drug Administration approval of the dispersible tablet formulation of the fixed-dose combination abacavir/dolutegravir/lamivudine (Triumeq PD).
The Panel on Opportunistic Infections in Adults and Adolescents updated the mpox section of the guidelines.
September 27 is National Gay Men’s HIV/AIDS Awareness Day. The annual observance is held each year to focus attention on the disproportionate impact of HIV and AIDS on gay and bisexual men.
The National Institutes of Health (NIH) Office of AIDS Research (OAR) joined the world's largest gathering on HIV/AIDS at the 24th International AIDS Conference (AIDS 2022).
The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated several sections of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV.
Hepatitis B and Immunization sections of the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV updated.
The HHS Panel on the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children (the Panel) updated the Guidelines and added a brief statement about mpox.
The Panel on Antiretroviral Guidelines for Adults and Adolescents updated the Drug–Drug Interactions tables with guidance on the interaction potentials between antiretroviral drugs and antiviral drugs currently being used to treat mpox.
National Immunization Awareness Month highlights the importance of getting recommended vaccines.
The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV.
Fact sheets from HIVinfo provide important information about ways to prevent perinatal transmission of HIV.
Please take a moment to update our contact information.
Today is National HIV Testing Day (NHTD), an annual occasion to raise awareness about the importance of HIV testing; encourage people to know their HIV status; and connect to prevention, care, and treatment services.
An updated infographic highlighting important information about HIV treatment is now available on HIVinfo. An updated infographic highlighting important information about HIV treatment is now available on HIVinfo.
Please take a moment to update our contact information. HIVinfo offers federally approved information about HIV treatment, research, and clinical trials in the United States to health care providers and consumers.